Clifford Woolf, MD, PhD

Dr. Woolf's expertise is in the study of pain and the elucidation of pain mechanisms in preclinical models and in patients using molecular biological, electrophysiological, genetic and behavioral techniques. He has examined the specific contribution of COX-2 expressed in the central nervous system to the generation of inflammatory pain and as the site of the analgesic action of selective and non-selective COX inhibitors using transgenic mouse models. He will contribute his expertise in studying and measuring the pain phenotype to the program.